Raul MD - Cingulate Warrants Executive Officer
| CINGW Stock | USD 0.03 0 10.00% |
Executive
Raul MD is Executive Officer of Cingulate Warrants
| Age | 66 |
| Address | 1901 West 47th Place, Kansas City, KS, United States, 66205 |
| Phone | 913 942 2300 |
| Web | https://www.cingulate.com |
Cingulate Warrants Management Efficiency
The company has return on total asset (ROA) of (1.0433) % which means that it has lost $1.0433 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (2.7382) %, meaning that it generated substantial loss on money invested by shareholders. Cingulate Warrants' management efficiency ratios could be used to measure how well Cingulate Warrants manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Cingulate Warrants' Return On Capital Employed is fairly stable compared to the past year. Return On Equity is likely to climb to 3.60 in 2024, despite the fact that Return On Tangible Assets are likely to grow to (6.40). At this time, Cingulate Warrants' Non Currrent Assets Other are fairly stable compared to the past year. Debt To Assets is likely to climb to 0.90 in 2024, whereas Total Assets are likely to drop slightly above 3.3 M in 2024.Similar Executives
| Found 8 records | EXECUTIVE Age | ||
| Ferenc MD | NeuroSense Therapeutics Ltd | 60 | |
| Keren Pushett | NeuroSense Therapeutics Ltd | N/A | |
| Thomas Dalton | Cingulate | N/A | |
| Hagit Binder | NeuroSense Therapeutics Ltd | 46 | |
| Matthew MD | Cingulate | 60 | |
| Jennifer Callahan | Cingulate | 53 | |
| Niva RussekBlum | NeuroSense Therapeutics Ltd | 45 | |
| Eidan Loushi | NeuroSense Therapeutics Ltd | N/A | |
Management Performance
| Return On Equity | -2.74 | ||||
| Return On Asset | -1.04 |
Cingulate Warrants Leadership Team
Elected by the shareholders, the Cingulate Warrants' board of directors comprises two types of representatives: Cingulate Warrants inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Cingulate. The board's role is to monitor Cingulate Warrants' management team and ensure that shareholders' interests are well served. Cingulate Warrants' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Cingulate Warrants' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Craig Esq, Gen VP | ||
| Dr MBA, Executive COO | ||
| Raul MD, Executive Officer | ||
| Thomas Dalton, Head Relations | ||
| Jennifer CPA, Senior CFO | ||
| Shane PharmD, CEO Board | ||
| PharmD PharmD, Principal CEO | ||
| Jennifer Callahan, Corporate Controller | ||
| Matthew MD, Executive Officer |
Cingulate Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Cingulate Warrants a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -2.74 | ||||
| Return On Asset | -1.04 | ||||
| Number Of Shares Shorted | 7.12 K | ||||
| EBITDA | (22.95 M) | ||||
| Net Income | (23.53 K) | ||||
| Cash And Equivalents | 1.92 M | ||||
| Cash Per Share | 0.17 X | ||||
| Total Debt | 3.14 M | ||||
| Debt To Equity | 0.45 % | ||||
| Current Ratio | 1.10 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Cingulate Stock Analysis
When running Cingulate Warrants' price analysis, check to measure Cingulate Warrants' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cingulate Warrants is operating at the current time. Most of Cingulate Warrants' value examination focuses on studying past and present price action to predict the probability of Cingulate Warrants' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cingulate Warrants' price. Additionally, you may evaluate how the addition of Cingulate Warrants to your portfolios can decrease your overall portfolio volatility.